Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 518-528
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.518
Figure 1
Figure 1 Kaplan-Meier survival curve for LATS2 expression.
Figure 2
Figure 2 Nomogram consisting of lymphatic invasion, LATS2, tumor size, and T and N stages.
Figure 3
Figure 3 Receiver operating characteristic curve of training set. A: Receiver operating characteristic (ROC) curve of TN stage; B: ROC curve of TN stage + LATS2; C: ROC curve of the target model.
Figure 4
Figure 4 Receiver operating characteristic curve of validation set. A: Receiver operating characteristic (ROC) curve of TN stage; B: ROC curve of TN stage + LATS2; C: ROC curve of the target model.
Figure 5
Figure 5 Calibration diagram of training set. A: Calibration diagram of TN stage; B: Calibration diagram of TN stage +LATS2; C: Calibration plot of the target model.
Figure 6
Figure 6 Calibration diagram of validation set. A: Calibration diagram of TN stage; B: Calibration diagram of TN stage +LATS2; C: Calibration plot of the target model.